CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.
May 6th 2024
Patients with TP53/PPM1D mutations in their stem cell product had an increased risk of myeloid neoplasms in patients with Hodgkin lymphoma undergoing autologous stem cell transplant.
FDA Agrees to Review CAR-T Cell Therapy for Second-Line Treatment of Large B-Cell Lymphoma
February 17th 2022The Food and Drug Administration will review data on Breyanzi (lisocabtagene maraleucel) — a CAR-T cell therapy — for use in the second-line setting for patients with relapsed or refractory large B-cell lymphoma to determine if the indication will be granted approval.
Trial Launched to Assess Safety and Efficacy of Novel Drug in Rare Type of Head and Neck Cancer
January 10th 2022A phase 2 trial was recently launched to examine the safety and efficacy of oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma.
FDA Approves Orencia for GVHD Prevention After Hematopoietic Stem Cell Transplant
December 15th 2021The Food and Drug Administration approved Orencia, which is commonly used to treat conditions like rheumatoid arthritis, to prevent acute graft-versus-host-disease in adults and children who underwent a hematopoietic stem cell transplant from an unrelated donor.
COVID-19 May Increase Mortality Risk in Older Patients With B-Cell Malignancies, Among Others
November 29th 2021Patients aged 60 years and older with B-cell malignancies and those who were current or former smokers may have an increased risk for death after a COVID-19 infection, also outcomes may be better for those diagnosed after June 2020.